A COMPARATIVE-STUDY OF PALA, PALA PLUS 5-FU, AND 5-FU IN ADVANCED BREAST-CANCER

被引:0
|
作者
MANN, GB
HORTOBAGYI, GN
BUZDAR, AU
YAP, HY
VALDIVIESO, M
机构
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DIV MED,MED BREAST SERV,6723 BERTNER AVE,HOUSTON,TX 77030
[2] MT ELIZABETH MED CTR,CTR CANC SCREENING & TREATMENT,SINGAPORE,SINGAPORE
[3] AMER INT HOSP,ZION,IL
关键词
D O I
10.1002/1097-0142(19850915)56:6<1320::AID-CNCR2820560617>3.0.CO;2-R
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1320 / 1324
页数:5
相关论文
共 50 条
  • [41] PHASE-I-PHASE-II CLINICAL-TRIAL OF THYMIDINE, 5-FU, AND PALA GIVEN IN COMBINATION
    CHIUTEN, DF
    VALDIVIESO, M
    BEDIKIAN, A
    BODEY, GP
    FREIREICH, EJ
    CANCER TREATMENT REPORTS, 1985, 69 (06): : 611 - 613
  • [42] TAMOXIFEN AND CONJUGATED ESTROGENS (PREMARIN) FOLLOWED BY SEQUENCED METHOTREXATE AND 5-FU IN REFRACTORY ADVANCED BREAST-CANCER
    EISENHAUER, EA
    BOWMAN, DM
    PRITCHARD, KI
    PATERSON, AHG
    RAGAZ, J
    PLENDERLEITH, I
    GEGGIE, PHS
    MAXWELL, I
    CANCER TREATMENT REPORTS, 1984, 68 (11): : 1421 - 1422
  • [43] 5-FU INFUSION AND CYCLOPHOSPHAMIDE IN TREATMENT OF ADVANCED OVARIAN CANCER
    IZBICKI, RM
    BAKER, LH
    SAMSON, MK
    MCDONALD, B
    VAITKEVICIUS, VK
    CANCER TREATMENT REPORTS, 1977, 61 (08): : 1573 - 1575
  • [44] Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer
    Thrall, MM
    Wood, P
    King, V
    Rivera, W
    Hrushesky, W
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (04): : 873 - 881
  • [45] Effect of the multiple modulation 5-FU in advanced gastric cancer
    Kuznetsova, EA
    Garin, AM
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S14 - S14
  • [46] PHASE II TRIAL OF SEQUENTIAL N-PHOSPHONACETYL-L-ASPARTATE (PALA), THYMIDINE (TDR), AND 5-FLUOROURACIL (5-FU) IN ADVANCED COLORECTAL-CANCER
    OCONNELL, M
    MOERTEL, C
    RUBIN, J
    HAHN, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 182 - 182
  • [47] Irinotecan plus 5-FU and leucovorin in advanced colorectal cancer: North American trials
    Goldberg, RM
    Erlichman, C
    ONCOLOGY-NEW YORK, 1998, 12 (08): : 59 - 63
  • [48] SEQUENTIAL METHOTREXATE PLUS 5-FU IN ADVANCED BREAST AND COLORECTAL CANCERS - A PHASE-II STUDY
    KAYE, SB
    SANGSTER, G
    HUTCHEON, A
    HABESHAW, T
    CROSSLING, F
    FERGUSON, C
    MCARDLE, C
    SMITH, D
    GEORGE, WD
    CALMAN, KC
    CANCER TREATMENT REPORTS, 1984, 68 (03): : 547 - 548
  • [49] Correct fluorouracil (5-FU) half-life comparator for a 5-FU prodrug plus a dihydropyrimidine dehydrogenase inhibitor
    White, RM
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) : 2970 - 2970
  • [50] INEFFICIENCY OF CISPLATIN PLUS 5-FU AS 2ND OR 3RD LINE TREATMENT IN ADVANCED BREAST-CANCER
    PALACIO, I
    BUESA, JM
    BARON, FJ
    LOPEZ, R
    CUEVA, JF
    ESTEBAN, E
    ESTRADA, E
    GRACIA, JM
    LACAVE, AJ
    ANNALS OF ONCOLOGY, 1991, 2 (07) : 521 - 521